Related Experiment Video
Updated: Mar 20, 2026

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
Beyond transcription factors: how oncogenic signalling reshapes the epigenetic landscape
Fan Liu1,2, Lan Wang3,4, Fabiana Perna5
1Department of Biochemistry and Molecular Biology, University of Miami, Miami, Florida 33136, USA.
Abstract:
Cancer, once thought to be caused largely by genetic alterations, is now considered to be a mixed genetic and epigenetic disease. The epigenetic landscape, which is dictated by covalent DNA and histone modifications, is profoundly altered in transformed cells. These abnormalities may arise from mutations in, or altered expression of, chromatin modifiers. Recent reports on the interplay between cellular signalling pathways and chromatin modifications add another layer of complexity to the already complex regulation of the epigenome. In this Review, we discuss these new studies and how the insights they provide can contribute to a better understanding of the molecular pathogenesis of neoplasia.
Insights
Cancer is a complex disease influenced by both genetic and epigenetic factors. Understanding epigenetic alterations and chromatin modifications is crucial for unraveling cancer
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Cancer is now recognized as a complex disease involving both genetic and epigenetic factors.
- The epigenetic landscape, regulated by DNA and histone modifications, is significantly altered in cancer cells.
- Aberrant epigenetic modifications can stem from mutations or altered expression of chromatin-modifying proteins.
Purpose of the Study:
- To review recent studies on the interplay between cellular signaling pathways and epigenetic modifications in cancer.
- To enhance understanding of the molecular pathogenesis of neoplasia through the lens of epigenetics.
Main Methods:
- Review of current scientific literature and recent reports.
- Analysis of the role of chromatin modifiers in cancer development.
- Exploration of the connection between cell signaling and epigenetic regulation.
Main Results:
- Epigenetic abnormalities are a hallmark of transformed cells.
- Interactions between signaling pathways and chromatin modifications add complexity to epigenome regulation.
- Mutations in chromatin modifiers contribute to epigenetic dysregulation in cancer.
Conclusions:
- Epigenetic alterations are integral to cancer development.
- Understanding these epigenetic changes offers new insights into cancer pathogenesis.
- Further research into signaling pathways and chromatin modifications is essential for advancing cancer research.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
09:58Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Epigenetic Regulation
Induced Pluripotent Stem Cells
Somatic...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...